Showing results (511-520 of 538) with videos related to
Sort By:
Pageof 54
Neuroscience|May 31, 2008
Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesiaD H Kim, B Fitzsimmons, M P Hefferan, et al.Arthritis Research & Therapy|July 29, 2018
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapyStanley B Cohen, Rieke Alten, Hideto Kameda, et al.Brain Communications|April 20, 2022
Diminished preparatory physiological responses in frontotemporal lobar degeneration syndromesKuan-Hua Chen, Alice Y Hua, Gianina Toller, et al.AJNR. American Journal of Neuroradiology|June 23, 2012
Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swineK-C Wei, H-C Tsai, Y-J Lu, et al.Scientific Reports|March 3, 2016
Antiferromagnetic proximity effect in epitaxial CoO/NiO/MgO(001) systemsQ Li, J H Liang, Y M Luo, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic EsophagitisEvan S Dellon, Margaret H Collins, Marc E Rothenberg, et al.Neuroimage. Clinical|September 28, 2017
Advancing functional dysconnectivity and atrophy in progressive supranuclear palsyJesse A Brown, Alice Y Hua, Andrew Trujllo, et al.Panminerva Medica|March 26, 2020
Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenuesMayuren Candasamy, Safa A Mohamed Elhassan, Subrat Kumar Bhattamisra, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 24, 2017
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patientsP W Collins, D V K Quon, M Makris, et al.Journal of Glaucoma|January 17, 2007
Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacyRichard A Lewis, Gregory J Katz, Mark J Weiss, et al.Pageof 54